- Filed
- May 8, 2026 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2026 · May 7, 2026 | 70.55M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2026 | 69.46M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2025 | 58.54M sh |
| Capex | Q1 2026 · Mar 31, 2026 | $51K |
| Capex | Q1 2026 · Mar 31, 2025 | $1.9M |
| Operating Cash Flow | Q1 2026 · Mar 31, 2026 | $5.27M |
| Operating Cash Flow | Q1 2026 · Mar 31, 2025 | $868K |
| Long Term Debt | Q1 2026 · Mar 31, 2026 | $39.36M |
| Long Term Debt | Q1 2026 · Dec 31, 2025 | $50.59M |
| Short Term Debt | Q1 2026 · Mar 31, 2026 | $5.46M |
| Short Term Debt | Q1 2026 · Dec 31, 2025 | $5.46M |
| Cash And Equivalents | Q1 2026 · Mar 31, 2026 | $16.69M |
| Cash And Equivalents | Q1 2026 · Dec 31, 2025 | $8.45M |
| Stockholders Equity | Q1 2026 · Mar 31, 2026 | $100.26M |
| Stockholders Equity | Q1 2026 · Dec 31, 2025 | $87.71M |
| Stockholders Equity restated | Q1 2026 · Mar 31, 2025 | $76.23M |
| Stockholders Equity restated | Q1 2026 · Dec 31, 2024 | $78.19M |
| Current Liabilities | Q1 2026 · Mar 31, 2026 | $32.48M |
| Current Liabilities | Q1 2026 · Dec 31, 2025 | $27.9M |
| Total Liabilities | Q1 2026 · Mar 31, 2026 | $91.74M |
| Total Liabilities | Q1 2026 · Dec 31, 2025 | $99.59M |
| Current Assets | Q1 2026 · Mar 31, 2026 | $24.33M |
| Current Assets | Q1 2026 · Dec 31, 2025 | $15.46M |
| Total Assets | Q1 2026 · Mar 31, 2026 | $192M |
| Total Assets | Q1 2026 · Dec 31, 2025 | $187.3M |
| Eps Diluted | Q1 2026 · Mar 31, 2026 | −$0.03 |
| Eps Diluted | Q1 2026 · Mar 31, 2025 | −$0.05 |
| Eps Basic | Q1 2026 · Mar 31, 2026 | −$0.03 |
| Eps Basic | Q1 2026 · Mar 31, 2025 | −$0.05 |
| Sga Expense | Q1 2026 · Mar 31, 2026 | $22.58M |
| Sga Expense | Q1 2026 · Mar 31, 2025 | $21.77M |
| Net Income | Q1 2026 · Mar 31, 2026 | −$2.4M |
| Net Income | Q1 2026 · Mar 31, 2025 | −$2.85M |
| Operating Income | Q1 2026 · Mar 31, 2026 | −$1.8M |
| Operating Income | Q1 2026 · Mar 31, 2025 | −$1.59M |
| Revenue | Q1 2026 · Mar 31, 2026 | $39.39M |
| Revenue | Q1 2026 · Mar 31, 2025 | $39.37M |